Yuval Cohen

Yuval Cohen

Vorstandsvorsitzender bei CORBUS PHARMACEUTICALS HOLDINGS, INC.

Vermögen: 447 388 $ am 31.05.2024

49 Jahre
Health Technology
Consumer Services

Ursprung des Netzwerks ersten Grades von Yuval Cohen

EinheitArt der EinheitIndustrie
Public Company Pharmaceuticals: Major 24
12
Extinct Pharmaceuticals: Major 12
11
Subsidiary Pharmaceuticals: Major 11

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Yuval Cohen

UnternehmenSektorVerknüpfte PersonenHauptposition
Pharmaceuticals: Major

Alan G. Harris

Yiu Nam Lau

Corporate Officer/Principal

Corporate Officer/Principal

AGENUS INC. Biotechnology

Renu Gupta

Corporate Officer/Principal

INSMED INCORPORATED Pharmaceuticals: Major

Renu Gupta

Chief Tech/Sci/R&D Officer

Investment Managers

George Golumbeski

Private Equity Analyst

Pharmaceuticals: Major

George Golumbeski

Corporate Officer/Principal

Pharmaceuticals: Major

Alan G. Harris

Anne Altmeyer

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Alan G. Harris

Paris Panayiotopoulos

Director/Board Member

Director/Board Member

AURA BIOSCIENCES, INC. Biotechnology

George Golumbeski

Chairman

BAXALTA INC Biotechnology

Jacques Suzanne

Anne Altmeyer

Corporate Officer/Principal

Corporate Officer/Principal

University of Virginia College/University

Avery Catlin

George Golumbeski

Undergraduate Degree

Undergraduate Degree

University of Pennsylvania College/University

Renu Gupta

Craig Millian

Brian Walsh

Corporate Officer/Principal

Undergraduate Degree

Undergraduate Degree

MORPHOSYS AG Biotechnology

George Golumbeski

Director/Board Member

Miscellaneous Commercial Services

Allan Shaw

Jacques Suzanne

Corporate Officer/Principal

Comptroller/Controller/Auditor

Biotechnology

George Golumbeski

Corporate Officer/Principal

Investment Managers

Gilead Raday

Private Equity Investor

University of Cambridge College/University

Gilead Raday

Dominic Smethurst

Graduate Degree

Undergraduate Degree

Babson College College/University

Avery Catlin

Sean Moran

Masters Business Admin

Undergraduate Degree

The Johns Hopkins University College/University

David Sidransky

Barbara White

Corporate Officer/Principal

Director/Board Member

The Hebrew University of Jerusalem College/University

Gilead Raday

Saul Yedgar

Graduate Degree

Corporate Officer/Principal

Pharmaceuticals: Major

Mark A. Tepper

Christina Bertsch

Craig Millian

Paris Panayiotopoulos

Chief Operating Officer

Human Resources Officer

Corporate Officer/Principal

President

NAVIOS MARITIME HOLDINGS INC. Marine Shipping

Allan Shaw

Director/Board Member

University of Strasbourg College/University

Alan G. Harris

Anne Altmeyer

Doctorate Degree

Doctorate Degree

Miscellaneous Commercial Services

Gilead Raday

Director/Board Member

The Royal College of Physicians College/University

Yiu Nam Lau

Dominic Smethurst

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

George Golumbeski

Corporate Officer/Principal

ECHO THERAPEUTICS, INC. Medical Specialties

Robert Francis Doman

Sean Moran

Chief Executive Officer

Director of Finance/CFO

Pharmaceuticals: Major

Gilead Raday

Chief Executive Officer

University of Zambia College/University

Renu Gupta

Doctorate Degree

Pharmaceuticals: Major

Renu Gupta

Director/Board Member

Harvard Medical School College/University

Renu Gupta

Corporate Officer/Principal

REDHILL BIOPHARMA LTD. Pharmaceuticals: Major

Gilead Raday

Chief Operating Officer

Biotechnology

George Golumbeski

Corporate Officer/Principal

AKARI THERAPEUTICS, PLC Biotechnology

Allan Shaw

David Sidransky

Dov Elefant

Gur Roshwalb

Jacques Suzanne

Director/Board Member

Director/Board Member

Director of Finance/CFO

Chief Executive Officer

Chief Executive Officer

PROVENTION BIO, INC. Pharmaceuticals: Major

Avery Catlin

John Jenkins

Director/Board Member

Director/Board Member

HLS THERAPEUTICS INC. Pharmaceuticals: Major

Craig Millian

Brian Walsh

Chief Executive Officer

Corporate Officer/Principal

Pharmaceuticals: Major

George Golumbeski

Dominic Smethurst

Director/Board Member

Chief Tech/Sci/R&D Officer

SHATTUCK LABS, INC. Biotechnology

George Golumbeski

Chairman

SAGE THERAPEUTICS, INC. Pharmaceuticals: Major

George Golumbeski

Director/Board Member

Pharmaceuticals: Major

Gilead Raday

Director/Board Member

Investment Managers

George Golumbeski

Consultant / Advisor

Pharmaceuticals: Major

George Golumbeski

Director/Board Member

Pharmaceuticals: Major

George Golumbeski

Director/Board Member

Medical Specialties

George Golumbeski

President

Statistik

International

Vereinigte Staaten 30
Vereinigtes Königreich 8
Israel 5
Deutschland 2
Cayman Islands 2

Sektoral

Health Technology 29
Consumer Services 11
Finance 4
Commercial Services 4
Transportation 2

Operativ

Director/Board Member 147
Corporate Officer/Principal 90
Chairman 41
Independent Dir/Board Member 39
Director of Finance/CFO 29
  1. Börse
  2. Insiders
  3. Yuval Cohen
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT